These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31004781)
21. Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator. Munir MB; Althouse AD; Rijal S; Shah MB; Abu Daya H; Adelstein E; Saba S J Cardiovasc Electrophysiol; 2016 Jun; 27(6):730-4. PubMed ID: 26856440 [TBL] [Abstract][Full Text] [Related]
22. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
23. Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). Buber J; Goldenberg I; Moss AJ; Wang PJ; McNitt S; Hall WJ; Eldar M; Barsheshet A; Shechter M J Am Coll Cardiol; 2012 Aug; 60(8):749-55. PubMed ID: 22703927 [TBL] [Abstract][Full Text] [Related]
24. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF; Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396 [TBL] [Abstract][Full Text] [Related]
25. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort. Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521 [TBL] [Abstract][Full Text] [Related]
26. Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study. Singh B; Hsieh YC; Liu YB; Lin KH; Joung B; Rodriguez DA; Chasnoits AR; Huang D; Zhang S; O'Brien JE; Lexcen DR; Cerkvenik J; Van Dorn B; Ching CK Indian Heart J; 2023; 75(2):115-121. PubMed ID: 36736459 [TBL] [Abstract][Full Text] [Related]
27. Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention. Barra S; Providência R; Boveda S; Duehmke R; Narayanan K; Chow AW; Piot O; Klug D; Defaye P; Gras D; Deharo JC; Milliez P; Da Costa A; Mondoly P; Gonzalez-Panizo J; Leclercq C; Heck P; Virdee M; Sadoul N; Le Heuzey JY; Marijon E Heart; 2018 Sep; 104(18):1529-1535. PubMed ID: 29540431 [TBL] [Abstract][Full Text] [Related]
28. Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients. Wang Y; Sharbaugh MS; Althouse AD; Mulukutla S; Saba S Indian Pacing Electrophysiol J; 2019; 19(1):4-6. PubMed ID: 30118798 [TBL] [Abstract][Full Text] [Related]
29. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study. Wang NC; Li JZ; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Mendenhall GS; Shalaby AA; Voigt AH; Saba S Pacing Clin Electrophysiol; 2018 Feb; 41(2):143-154. PubMed ID: 29314085 [TBL] [Abstract][Full Text] [Related]
31. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2018; 18(7):1-199. PubMed ID: 30443279 [TBL] [Abstract][Full Text] [Related]
32. Women with nonischemic cardiomyopathy have a favorable prognosis and a better left ventricular remodeling than men after cardiac resynchronization therapy. Cipriani M; Landolina M; Oliva F; Ghio S; Vargiu S; Rordorf R; Raineri C; Ammirati E; Petracci B; Campo C; Bisetti S; Lunati M J Cardiovasc Med (Hagerstown); 2016 Apr; 17(4):291-8. PubMed ID: 25222077 [TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study. Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523 [TBL] [Abstract][Full Text] [Related]
34. Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate. Barra S; Boveda S; Providência R; Sadoul N; Duehmke R; Reitan C; Borgquist R; Narayanan K; Hidden-Lucet F; Klug D; Defaye P; Gras D; Anselme F; Leclercq C; Hermida JS; Deharo JC; Looi KL; Chow AW; Virdee M; Fynn S; Le Heuzey JY; Marijon E; Agarwal S; J Am Coll Cardiol; 2017 Apr; 69(13):1669-1678. PubMed ID: 28359511 [TBL] [Abstract][Full Text] [Related]
35. Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up. Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT JACC Heart Fail; 2017 Mar; 5(3):204-212. PubMed ID: 28254126 [TBL] [Abstract][Full Text] [Related]
36. Cardiac resynchronization therapy response in cardiac sarcoidosis. Shabtaie SA; Sehrawat O; Lee JZ; Cha YM; Mulpuru SK; Kowlgi NG; Siontis KC; Rosenbaum AN; Bois JP; AbouEzzeddine OF; Noseworthy PA; Asirvatham SJ; DeSimone CV; Deshmukh AJ J Cardiovasc Electrophysiol; 2022 Sep; 33(9):2072-2080. PubMed ID: 35870183 [TBL] [Abstract][Full Text] [Related]
37. An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy. Liu F; Gao X; Luo J Front Cardiovasc Med; 2023; 10():1078570. PubMed ID: 37502189 [TBL] [Abstract][Full Text] [Related]
38. Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy. Singh JP; Solomon SD; Fradley MG; Barac A; Kremer KA; Beck CA; Brown MW; McNitt S; Schleede S; Zareba W; Goldenberg I; Kutyifa V; JAMA; 2019 Nov; 322(18):1799-1805. PubMed ID: 31714987 [TBL] [Abstract][Full Text] [Related]
39. Survival and Heart Failure Hospitalization in Patients With Cardiac Resynchronization Therapy With or Without a Defibrillator for Primary Prevention in Japan - Analysis of the Japan Cardiac Device Treatment Registry Database. Yokoshiki H; Shimizu A; Mitsuhashi T; Furushima H; Sekiguchi Y; Manaka T; Nishii N; Ueyama T; Morita N; Okamura H; Nitta T; Hirao K; Okumura K; Circ J; 2017 Nov; 81(12):1798-1806. PubMed ID: 28626201 [TBL] [Abstract][Full Text] [Related]
40. Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report From the National Cardiovascular Data Registry. Friedman DJ; Bao H; Spatz ES; Curtis JP; Daubert JP; Al-Khatib SM Circulation; 2016 Nov; 134(21):1617-1628. PubMed ID: 27760795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]